Skip to main content

Table 1 General characteristic of NAFLD patients.

From: Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study

  Steatohepatitis (n 20) Diffuse Steatosis(n 27) Focal Fatty Liver (n 3) Controls (n 50)
Age(years) 54.1 ± 13.2 45.1 ± 6.3 56.1 ± 3.1 43.8 ± 17.5
BMI (kg\m2) 30.6 ± 1.4 34.7 ± 4.5 26.7 ± 0.5 28.1 ± 5.3*
ALT (U\l) 68.0 ± 12.7 69.6 ± 16.2 42.0 ± 15.0 28.4 ± 1.1*
AST (U\l) 54.1 ± 13.2 45.2 ± 6.3 68.0 ± 7.0 27.3 ± 1.2*
GGT 62.8 ± 9.9 53.2 ± 5.9 48.0 ± 8.1 49.3 ± 8.5
Cholesterol (mg\dl) 203.8 ± 15.2 174.0 ± 13.3 167.0 ± 10.2 171 ± 10.1
Triglyceride (mg\dl) 214.0 ± 47.4 134.8 ± 15.9 73.0 ± 15.2 90 ± 10.5
HOMA-IR 6.2 ± 1.4 4.9 ± 0.9 1.5 ± 0.8 1.4 ± 0.8*
USG Steatosis Grade 2.04 ± 0.01 1.87 ± 0.22 0 0
  1. *BMI of healthy controls was lower than steatohepatitis and steatosis patients. Liver function tests, HOMA-IR value were significantly higher in NAFLD groups compared to controls (p < 0.01)